2022 CDC Clinical Practice Guideline for Prescribing Opioids Implementation Guide
2022.1.0 - CI Build

2022 CDC Clinical Practice Guideline for Prescribing Opioids Implementation Guide, published by Centers for Disease Control and Prevention (CDC). This guide is not an authorized publication; it is the continuous build for version 2022.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cqframework/opioid-cds-r4/ and changes regularly. See the Directory of published versions

Table of Contents

.. 0 Table of Contents
... 1 Home
... 2 2022 CDC Clinical Practice Guideline - Profiles
... 3 2022 CDC Clinical Practice Guideline - Terminology
... 4 2022 CDC Clinical Practice Guideline - Examples
... 5 2022 CDC Clinical Practice Guideline - Documentation
.... 5.1 2022 CDC Clinical Practice Guideline - Implementation Documentation
.... 5.2 2022 CDC Clinical Practice Guideline - Integration Documentation
.... 5.3 2022 CDC Clinical Practice Guideline - Process Documentation
.... 5.4 2022 CDC Clinical Practice Guideline - Service Documentation
... 6 2022 CDC Clinical Practice Guideline - Downloads
... 7 2022 CDC Clinical Practice Guideline - Subroutines
... 8 2022 CDC Clinical Practice Guideline - Acute Pain
... 9 2022 CDC Clinical Practice Guideline - Quick Start
... 10 Chronic Pain Decision Documentation
... 11 Recommendation #1 - Nonpharmacologic and Nonopioid Pharmacologic Therapy Consideration
... 12 Recommendation #2 - Opioid Therapy Goals Discussion
... 13 Recommendation #3 - Opioid Immediate Release Form When Starting Opioid Therapy
... 14 Recommendations #4 and #5 - Lowest Effective Dose
... 15 Recommendation #6 - Prescribe Lowest Effective Dose and Duration
... 16 Recommendation #7 - Opioid Therapy Risk Assessment
... 17 Recommendation #8 - Naloxone Consideration
... 18 Recommendation #9 - Consider Patient's History of Controlled Substance Prescriptions
... 19 Recommendation #10 - Urine Drug Testing
... 20 Recommendation #11 - Concurrent Use of Opioids and Benzodiazepines
... 21 Recommendation #12 - Evidence-based Treatment for Patients with Opioid Use Disorder
... 22 License and Legal Terms
... 23 Artifacts Summary
.... 23.1 HelloWorld
.... 23.2 HelloWorldPatientView
.... 23.3 CDCMMEClinicalConversionFactors
.... 23.4 OpioidCDSRoutines
.... 23.5 OpioidCDSCommon
.... 23.6 OpioidCDSCommonConfig
.... 23.7 OpioidLogicMK2020
.... 23.8 OpioidData2020
.... 23.9 FHIRHelpers
.... 23.10 FHIRModelInfo
.... 23.11 OpioidCDSREC10CommonLibrary
.... 23.12 OpioidCDSREC01Library
.... 23.13 OpioidCDSREC02Library
.... 23.14 OpioidCDSREC03Library
.... 23.15 OpioidCDSREC04And05Library
.... 23.16 OpioidCDSREC06Library
.... 23.17 OpioidCDSREC07Library
.... 23.18 OpioidCDSREC08Library
.... 23.19 OpioidCDSREC09Library
.... 23.20 OpioidCDSREC10Library
.... 23.21 OpioidCDSREC10PatientViewLibrary
.... 23.22 OpioidCDSREC11Library
.... 23.23 OpioidCDSREC11PatientViewLibrary
.... 23.24 OpioidCDSREC12PatientViewLibrary
.... 23.25 OpioidRiskAssessmentActivityDefinition
.... 23.26 OpioidUrineScreeningActivityDefinition
.... 23.27 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #1
..... 23.27.1 Library
.... 23.28 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #2
..... 23.28.1 Library
.... 23.29 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #3
..... 23.29.1 Library
.... 23.30 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendations #4 and #5
..... 23.30.1 Library
.... 23.31 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #6
..... 23.31.1 Library
.... 23.32 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #7
..... 23.32.1 Library
.... 23.33 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #8 (order-sign)
..... 23.33.1 Library
.... 23.34 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #8
..... 23.34.1 Library
.... 23.35 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #9
..... 23.35.1 Library
.... 23.36 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #10 (order-sign)
..... 23.36.1 Library
.... 23.37 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #10 (patient-view)
..... 23.37.1 Library
.... 23.38 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #10
..... 23.38.1 Library
.... 23.39 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #11 (patient-view)
..... 23.39.1 Library
.... 23.40 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #11
..... 23.40.1 Library
.... 23.41 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #12 (patient-view)
..... 23.41.1 Library
.... 23.42 Morphine Milligram Equivalent (MME) Conversion Factors for FHIR R4
.... 23.43 Morphine Milligram Equivalent (MME) Calculator for FHIR R4
.... 23.44 Opioid Management Terminology Knowledge Data
.... 23.45 Opioid Management Terminology Knowledge Logic
.... 23.46 CDC_CarePlan
.... 23.47 CDC_MedicationRequest
.... 23.48 CDC_Observation
.... 23.49 CDC_RequestGroup
.... 23.50 CDC_ValueSet
.... 23.51 DataDateRollerExtension
.... 23.52 EffectiveDataRequirement Extension
.... 23.53 CDC 2022 Opioid Guidance Clinical Focus Extension
.... 23.54 CDC 2022 Opioid Guidance Data Element Extension
.... 23.55 CDC 2022 Opioid Guidance exclusion Criteria Extension
.... 23.56 CDC 2022 Opioid Guidance Inclusion Criteria Extension
.... 23.57 ValueSet - Medication Request Category Community
.... 23.58 ValueSet - Medication Request Status Active
.... 23.59 CodeSystem - CDC 2022 Opioid Indicator
.... 23.60 OpioidCDS CarePlan
.... 23.61 Cancer Diagnosis Condition
.... 23.62 End of Life Condition
.... 23.63 Terminal Condition
.... 23.64 Cancer Diagnosis Encounter
.... 23.65 Oncology Participant Encounter
.... 23.66 Ambulatory Opioid MedicationDispense
.... 23.67 OpioidCDS MedicationRequest
.... 23.68 Ambulatory Opioid MedicationRequest
.... 23.69 OpioidCDS Observation
.... 23.70 OpioidCDS Patient
.... 23.71 Oncology Specialist PractitionerRole
.... 23.72 OpioidCDS RequestGroup
.... 23.73 Palliative Care ServiceRequest
.... 23.74 Ethanol urine drug screening tests
.... 23.75 Amphetamine-class drugs and metabolite urine tests
.... 23.76 Amphetamine class medications
.... 23.77 Benzodiazepine medications
.... 23.78 Buprenorphine and Methadone medications
.... 23.79 Cannabinoid class urine drug screening
.... 23.80 CDC malignant cancer conditions
.... 23.81 CNS depressant medications
.... 23.82 Cocaine urine drug screening tests
.... 23.83 Sleep disordered breathing
.... 23.84 Conditions documenting substance misuse
.... 23.85 Conditions likely terminal for opioid prescribing
.... 23.86 Extended release opioid with ambulatory misuse potential
.... 23.87 Fentanyl-type medications
.... 23.88 Fentanyl-type urine drug screening tests
.... 23.89 General opiate urine drug screening tests
.... 23.90 Hospice Finding
.... 23.91 Hospice Procedure
.... 23.92 Limited life expectancy conditions
.... 23.93 Methadone urine drug screening tests
.... 23.94 Methadone medications
.... 23.95 Naloxone medications
.... 23.96 Ambulatory setting non-opioid CNS depressant medications
.... 23.97 Non-opioid drug urine screening
.... 23.98 Non-synthetic opioid medications
.... 23.99 Oncology specialty designations (NUCC)
.... 23.100 Opiate specific urine drug screening tests
.... 23.101 Opioid analgesics with ambulatory misuse potential
.... 23.102 Opioid counseling procedure
.... 23.103 Opioid drug urine screening
.... 23.104 Opioid misuse assessment procedure
.... 23.105 Opioid misuse disorders
.... 23.106 Opioid treatment assessment procedure
.... 23.107 Pain management procedure
.... 23.108 Pain treatment plan
.... 23.109 PDMP data reviewed finding
.... 23.110 PDMP review procedure
.... 23.111 Phencyclidine urine drug screening tests
.... 23.112 Sickle-cell diseases
.... 23.113 Substance misuse behavioral counseling
.... 23.114 Synthetic opioid medications
.... 23.115 Synthetic opioid urine drug screening tests
.... 23.116 Therapies indicating end of life care
.... 23.117 Condition Clinical Status Active
.... 23.118 Encounter Diagnosis Condition Category
.... 23.119 Problem List Condition Category
.... 23.120 US Core Health Concern Condition Category
.... 23.121 Hospice Disposition
.... 23.122 Observation Category Laboratory
.... 23.123 Observation Category Procedure
.... 23.124 Office Visit
.... 23.125 Xylazine drug urine screening tests
.... 23.126 CQFToolingDevice